StockData
Teladoc Health, Inc. logo

Teladoc Health, Inc. (TDOC) stock

TDOCNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3043% below fair value
$7.45−0.34 (-4.36%)

Close on Nov 20, 2026Market cap $1.36BP/E –Yield –

Teladoc Health free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Teladoc Health's free cash flow for the twelve months ending Sep 30, 2026 was $261.96M, down 6.5% year over year. For fiscal 2025 it was $285.46M, up 0.9% from the year before. The highest annual figure on record is $338.56M in fiscal 2023.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$285.46M+0.9%
FY2024Dec 31, 2024$282.89M-16.4%
FY2023Dec 31, 2023$338.56M+95.9%
FY2022Dec 31, 2022$172.81M-6.8%
FY2021Dec 31, 2021$185.46M–
FY2020Dec 31, 2020-$57.54M-318.3%
FY2019Dec 31, 2019$26.36M–
FY2018Dec 31, 2018-$8.87M–
FY2017Dec 31, 2017-$37.07M–
FY2016Dec 31, 2016-$53.98M–
FY2015Dec 31, 2015-$53.46M–
FY2014Dec 31, 2014-$12.43M–
FY2013Dec 31, 2013-$6.26M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$105.24M+8.5%
Q2 FY2026Jun 30, 2026$63.73M-29.3%
Q1 FY2026Mar 31, 2026$7.86M-40.5%
Q4 FY2025Dec 31, 2025$85.12M+6.7%
Q3 FY2025Sep 30, 2025$96.98M-10.7%
Q2 FY2025Jun 30, 2025$90.16M+3.9%
Q1 FY2025Mar 31, 2025$13.19M+69.8%
Q4 FY2024Dec 31, 2024$79.77M-38.0%
Q3 FY2024Sep 30, 2024$108.58M+8.8%
Q2 FY2024Jun 30, 2024$86.77M-12.6%
Q1 FY2024Mar 31, 2024$7.77M-28.0%
Q4 FY2023Dec 31, 2023$128.68M+116.8%
Q3 FY2023Sep 30, 2023$99.81M+68.6%
Q2 FY2023Jun 30, 2023$99.28M+10.4%
Q1 FY2023Mar 31, 2023$10.79M–
Q4 FY2022Dec 31, 2022$59.35M-26.1%
Q3 FY2022Sep 30, 2022$59.19M-21.5%
Q2 FY2022Jun 30, 2022$89.93M+80.1%
Q1 FY2022Mar 31, 2022-$35.66M–
Q4 FY2021Dec 31, 2021$80.29M–
Q3 FY2021Sep 30, 2021$75.39M+143.5%
Q2 FY2021Jun 30, 2021$49.93M+43.2%
Q1 FY2021Mar 31, 2021-$20.14M–
Q4 FY2020Dec 31, 2020-$116.09M-764.9%
Q3 FY2020Sep 30, 2020$30.96M+160.4%
Q2 FY2020Jun 30, 2020$34.87M+537.3%
Q1 FY2020Mar 31, 2020-$7.28M–
Q4 FY2019Dec 31, 2019$17.46M+1358.6%
Q3 FY2019Sep 30, 2019$11.89M+25.6%
Q2 FY2019Jun 30, 2019$5.47M–
Q1 FY2019Mar 31, 2019-$8.46M–
Q4 FY2018Dec 31, 2018$1.20M–
Q3 FY2018Sep 30, 2018$9.46M–
Q2 FY2018Jun 30, 2018-$5.10M–
Q1 FY2018Mar 31, 2018-$14.43M–
Q4 FY2017Dec 31, 2017-$7.87M–
Q3 FY2017Sep 30, 2017-$12.49M–
Q2 FY2017Jun 30, 2017-$3.59M–
Q1 FY2017Mar 31, 2017-$13.13M–
Q4 FY2016Dec 31, 2016-$8.52M–

More Teladoc Health figures

See a number that looks wrong?